These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6089410)

  • 1. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained.
    Reisman D; Sugden B
    Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
    Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
    Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
    Cho MS; Gissmann L; Hayward SD
    Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV.
    Fresen KO; Cho MS; Gissmann L; zur Hausen H
    Intervirology; 1980; 12(6):303-10. PubMed ID: 6244234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
    J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
    Lupton S; Levine AJ
    Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
    Gergely L; Luka J; Klein G
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular size variation of EBNA is determined by the EB viral genome.
    Gergely L; Sternås L; Dillner J; Klein G
    Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA) by a two-site enzyme immunoassay, in parallel with EBV-DNA.
    Sternås L; Eliasson L; Lerner R; Klein G
    J Immunol Methods; 1986 May; 89(2):151-8. PubMed ID: 3009623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.
    Rawlins DR; Milman G; Hayward SD; Hayward GS
    Cell; 1985 Oct; 42(3):859-68. PubMed ID: 2996781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins.
    Young LS; Finerty S; Brooks L; Scullion F; Rickinson AB; Morgan AJ
    J Virol; 1989 May; 63(5):1967-74. PubMed ID: 2539497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
    Dambaugh T; Hennessy K; Chamnankit L; Kieff E
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7632-6. PubMed ID: 6209719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
    Tomkinson B; Kieff E
    J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
    Allday MJ; MacGillivray AJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.